Corporate News
RESTORATION OF TRADING ON AIM
14 March 2023
Trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 14/03/2023 07:30am, an announcement having been made.
ORDINARY SHARES OF GBP0.00037 EACH, FULLY PAID (BF3DT58) (GB00BF3DT583)
If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 7710 7600.
Latest News
-
Expansion of Xenon MRI imaging platform for pharma-sponsored research
10 March 2025 -
FY24 Trading Update
27 February 2025 -
Virtual Investor Day
19 February 2025
About Us
Latest Annual Report
Investor Alert
Sign up for Email Alerts